03-04-2025
Novo Nordisk Loses Another Executive as 28-Year Veteran Departs
Novo Nordisk A/S executive Camilla Sylvest is leaving the Danish drugmaker after almost three decades, the company's second high-profile departure in a month as it battles to maintain its share of the booming market for weight-loss treatments.
Sylvest, part of the leadership team, spent the last seven years as executive vice president for commercial strategy and corporate affairs at Novo Nordisk, and was close to Chief Executive Officer Lars Fruergaard.
